Christoph Nabholz and his team do applied R&D aimed at improving the understanding of trends and developments in human behaviour, morbidity and mortality. The gained R&D insights are used to strengthen the performance and innovation of L&H products. Through providing thought leadership on key strategic topics for L&H such as, genetic testing, ageing populations and consumer health behaviours, he and his team prompt debate and initiate the co-creation of novel insurance solutions.
From 2007 to 2016 Christoph Nabholz headed Business Development at the Swiss Re Centre for Global Dialogue, where he and his team were mandated to develop dialogue and debate, with experts at world class institutions, on key insurance industry topics. The team addressed issues across the many lines of business written by the firm and helped position Swiss Re as a knowledge company and industry leader.
From 2002 to 2006, Christoph Nabholz was in Swiss Re Global Life & Health Underwriting and served as Swiss Re’s Global Genetics Consultant.
From 1999 to 2002, he was a postdoctoral research fellow in genomics and functional genetics at Harvard University.
Christoph Nabholz received a diploma in biochemistry from the University of Basel and a PhD with honours in molecular genetics from the University of Freiburg in Switzerland.